TN HB1157

Tennessee Department of Health, local health departments, and state executive branch are prohibited from promoting information about FDA-regulated vaccines, masks, or emergency use authorized products that conflicts with FDA-approved labeling or implies safety/effectiveness for co-administration without completed clinical trials

Internal review process for FDA labeling compliance must be established by July 1, 2025, with annual compliance reports due to the attorney general beginning January 15, 2026

Non-compliant informational materials in print or electronic format must be removed from public distribution by January 15, 2026

Employees violating the act face disciplinary action including termination; entities receiving state or federal funds distributed by the state face civil penalties up to three times misused resources or $50,000 (whichever is greater) and potential funding ineligibility for 1-10 years

Attorney general may establish a complaint process, investigate violations, and assess penalties; referrals to outside sources about FDA-regulated products must include a warning that the source is not regulated by this act